# US Arterial Blood Collection Devices Market

> United States Arterial Blood Collection Devices Market Research Report: Size, Share, Trend Analysis - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.32%
- **2024:** $ 443.45 Million
- **2025:** $ 467.04 Million
- **2035:** $ 784.27 Million
- **Key Players:** Abbott Laboratories (US), Becton Dickinson and Company (US), Terumo Corporation (JP), F. Hoffmann-La Roche AG (CH), Greiner Bio-One International GmbH (AT), Cardinal Health, Inc. (US), Smiths Medical (US), Medtronic plc (IE)

**Report ID:** MRFR/MED/11399-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-arterial-blood-collection-devices-market-12924

---

## Market Summary

## US Arterial Blood Collection Devices Market Highlighted Trends & Dynamics

The biggest market for arterial blood collection devices is in the Americas, which includes two regions: North America and South America. Some important reasons for the growth of this market are the need for safe and reliable blood collection devices, the presence of major companies making these devices, and the widespread requirement for diagnostic services. However, a challenge for this market is the risk of infections from blood transfusions.

In 2016, North America had the largest share in the market. This was because there was a higher demand for diagnostic procedures, more awareness about using sterile devices for blood collection, and advancements in clinical diagnostics technology. Also, the increase in surgical procedures and the high prevalence of lifestyle diseases are contributing to the market's growth. According to America's Blood Centres, one in every seven people entering the hospital needs blood. In the U.S., more than 15 million pints of blood are transfused every year, and over 40 thousand pints of blood are transfused daily in the U.S. and Canada.

In South America, rapid population growth and the need for diagnostic and blood collection devices are driving the market. In the U.S., which is a significant part of the Americas market, it held 65.9% of the market share in 2016 and is expected to reach USD 400.3 million by 2023. South America is anticipated to grow the fastest during the forecast period.

Looking at the types of devices, blood collection tubes held 40.0% of the market share in the Americas in 2016 and are expected to reach USD 236.3 million by 2023. Among the types, needles are predicted to grow the fastest. For applications, arterial blood gas sampling held 80.2% of the market share in 2016 and is expected to reach USD 488.0 million by 2023, with intraoperative blood salvage growing the fastest. In terms of end-users, hospitals and clinics held 62.7% of the market share in 2016 and are expected to reach USD 379.1 million by 2023.

Blood banks are projected to grow the fastest during the forecast period.

In the U.S. alone, the market for arterial blood collection devices in 2016 saw blood collection tubes holding 39.1% of the market share, projected to reach USD 151.2 million by 2023. Needles are expected to grow the fastest among the types. Arterial blood gas sampling held 80.3% of the market share in 2016 and is expected to reach USD 320.3 million by 2023, with intraoperative blood salvage growing the fastest at 8.3% during the forecast period.

## Market Drivers

### Growing Awareness of Blood Donation

The increasing awareness of the importance of blood donation significantly influences the arterial blood-collection-devices market. Campaigns promoting blood donation and the establishment of blood donation centers across the US have led to a heightened demand for efficient blood collection devices. Organizations such as the American Red Cross actively engage in initiatives to encourage voluntary blood donations, which in turn drives the need for advanced arterial blood-collection devices. The market is likely to benefit from this trend, as improved devices can enhance the overall donation experience, making it more appealing for potential donors. This growing awareness and participation in blood donation initiatives are expected to contribute positively to the arterial blood-collection-devices market.

### Rising Demand for Diagnostic Testing

The arterial blood-collection-devices market experiences a notable surge in demand due to the increasing prevalence of chronic diseases such as diabetes and cardiovascular disorders. As healthcare providers emphasize early diagnosis and continuous monitoring, the need for efficient blood collection methods becomes paramount. In the US, the market for diagnostic testing is projected to reach approximately $70 billion by 2026, indicating a robust growth trajectory. This trend is likely to drive innovation in arterial blood-collection devices, enhancing their efficiency and reliability. Furthermore, the growing awareness among patients regarding the importance of regular health check-ups contributes to the rising demand for these devices, thereby propelling the arterial blood-collection-devices market forward.

### Technological Innovations in Device Design

Technological advancements play a crucial role in shaping the arterial blood-collection-devices market. Innovations such as automated blood collection systems and smart devices equipped with sensors are transforming traditional practices. These advancements not only improve the accuracy of blood sampling but also enhance patient comfort and reduce the risk of complications. The integration of digital technologies, such as mobile applications for tracking blood collection, is also gaining traction. As a result, the market is expected to witness a compound annual growth rate (CAGR) of around 6% over the next five years. This growth is indicative of the increasing investment in research and development aimed at creating more efficient and user-friendly arterial blood-collection devices.

### Regulatory Support for Innovative Solutions

Regulatory bodies in the US are increasingly supportive of innovations in the arterial blood-collection-devices market. Initiatives aimed at expediting the approval process for new medical devices encourage manufacturers to invest in research and development. The Food and Drug Administration (FDA) has implemented programs that facilitate faster access to market for breakthrough technologies, which is likely to stimulate competition and innovation. As a result, the market is expected to see a rise in the introduction of advanced arterial blood-collection devices that meet stringent safety and efficacy standards. This regulatory environment not only fosters innovation but also enhances consumer confidence in the products available, thereby positively influencing the growth of the arterial blood-collection-devices market.

### Increasing Focus on Home Healthcare Solutions

The shift towards home healthcare solutions significantly impacts the arterial blood-collection-devices market. With an aging population and a growing preference for at-home medical services, there is a rising need for devices that facilitate blood collection outside traditional clinical settings. This trend is further supported by advancements in telemedicine, which enable remote monitoring and consultations. The market for home healthcare is projected to reach $300 billion by 2025 in the US, suggesting a substantial opportunity for arterial blood-collection devices designed for home use. Consequently, manufacturers are likely to focus on developing portable and easy-to-use devices that cater to this emerging segment, thereby driving growth in the arterial blood-collection-devices market.

## Future Outlook

The [Arterial Blood Collection Devices Market](https://www.marketresearchfuture.com/reports/arterial-blood-collection-devices-market-4160) is projected to grow at a 5.32% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands.

**New opportunities:**

- Development of smart blood-collection devices with integrated data analytics capabilities.
- Expansion of mobile blood-collection units for remote patient access.
- Partnerships with telehealth platforms to enhance patient engagement and service delivery.

By 2035, the market is expected to achieve robust growth, reflecting evolving healthcare needs.

## Segment Insights

### By Type: Syringes (Largest) vs. Safety Blood Collection Devices (Fastest-Growing)

In the US arterial blood-collection-devices market, syringes hold the largest market share, primarily due to their widespread usage in hospitals and clinics for routine blood draws. Needles and collection tubes also contribute significantly to market dynamics, with needles experiencing steady demand driven by their application in various medical procedures. Safety blood collection devices, while smaller in share, are gaining traction due to increasing healthcare regulations and patient safety concerns.

Growth trends in this segment are strongly influenced by innovations aimed at reducing the risk of needlestick injuries and improving patient comfort. Safety blood collection devices are emerging as the fastest-growing segment, fueled by advancements in technology and heightened awareness of the importance of safe blood collection practices. Moreover, the increasing number of diagnostic procedures and the rising demand for blood testing are enhancing the overall growth potential of this segment.

Syringes (Dominant) vs. Safety Blood Collection Devices (Emerging)

Syringes are the dominant force in the arterial blood-collection-devices market, thanks to their versatility and ease of use in various clinical settings. They are essential for drawing blood samples efficiently and are often preferred for their compatibility with other medical tools. Conversely, safety blood collection devices represent an emerging category that is rapidly gaining popularity due to their innovative designs aimed at minimizing the risk of needle-stick injuries. These devices often come equipped with safety features that not only protect healthcare workers but also promote better hygiene practices. As hospitals and clinics prioritize patient and staff safety, the demand for these emerging devices is expected to rise significantly, setting them apart in a competitive market.

### By End User: Diagnostic Laboratories (Largest) vs. Hospitals (Fastest-Growing)

In the US arterial blood-collection-devices market, the distribution of market share among end users reveals that diagnostic laboratories hold the largest portion due to their critical role in conducting tests and analysis. Hospitals follow closely, serving as essential facilities where a significant number of blood collections occur. Blood banks, while vital, represent a smaller segment of the market, primarily focused on storage and supply management of collected blood samples.

Growth trends indicate a robust expansion in hospitals as they increasingly adopt advanced blood collection devices, driven by the growing demand for accurate diagnostics and minimally invasive procedures. Meanwhile, diagnostic laboratories are continually enhancing their capabilities with innovative technologies, establishing themselves as leaders in the market. Blood banks, though growing at a slower pace, are adapting to meet increasing requirements for safe blood supply management amid rising awareness of the importance of blood donation and storage.

Hospitals (Dominant) vs. Blood Banks (Emerging)

Hospitals remain the dominant end user in the market, leveraging their extensive infrastructure and resources to facilitate a high volume of blood collection procedures. This segment benefits from advancements in medical technology and initiatives aimed at improving patient outcomes, ensuring an ongoing need for efficient blood collection devices. In contrast, blood banks are emerging as a crucial player, focusing on optimizing the processes of blood collection, storage, and distribution. The drive for enhanced safety measures and regulatory compliance is pushing blood banks to invest in more sophisticated blood collection devices, making them a growing segment. While hospitals capitalize on high patient turnover, blood banks are carving out a new niche in specialized blood management capabilities, indicating a shift in market dynamics.

### By Application: Diagnostic Testing (Largest) vs. Blood Donation (Fastest-Growing)

In the US arterial blood-collection-devices market, Diagnostic Testing holds the largest share among the application segments, owing to the high demand for accurate and timely diagnostics in healthcare settings. This segment is critical for various medical tests, driving a significant portion of the market activity. Blood Donation, while comparatively smaller presently, is witnessing rapid growth due to increasing awareness and organizational efforts to boost donation rates, resulting in new initiatives and technologies that support this cause.

Growth trends in the US arterial blood-collection-devices market indicate a shift towards enhanced technologies that support both Diagnostic Testing and Blood Donation. Factors such as an increasing population, advances in medical devices, and a heightened focus on preventative care are propelling growth. Moreover, the rise in chronic diseases is further bolstering the demand for effective diagnostic testing solutions, while Blood Donation is gaining traction as more health organizations promote awareness campaigns and community engagement efforts.

Diagnostic Testing (Dominant) vs. Blood Donation (Emerging)

Diagnostic Testing is firmly positioned as the dominant segment within the US arterial blood-collection-devices market, characterized by robust demand driven by hospitals and laboratory settings seeking efficient testing processes. The emphasis on precise diagnostics and patient safety ensures that this segment remains vital for healthcare providers. Blood Donation, on the other hand, is emerging rapidly as a significant segment, reflecting the increasing need for blood supply and various initiatives aimed at streamlining the donation process. Enhanced collection devices and donor engagement strategies are being developed to strengthen this segment's position, which is not only critical for medical procedures but also integral to community health enhancements.

### By Material: Plastic (Largest) vs. Glass (Fastest-Growing)

In the US arterial blood-collection-devices market, the material segment showcases distinct trends among its core values: plastic, glass, and synthetic materials. Currently, plastic holds the largest share, driven by its cost-effectiveness and widespread use in various healthcare settings. Glass, while representing a smaller portion of the market, is gaining traction due to its perceived advantages in certain applications, particularly in high-precision environments.

The growth trends for this segment indicate a shifting preference towards glass as the fastest-growing material category in the US arterial blood-collection-devices market. This shift is largely attributed to advancements in glass manufacturing that enhance safety and decrease contamination risks. Moreover, increasing awareness about sustainability further propels the demand for glass solutions over traditional plastics, reflecting a broader industry trend towards eco-friendly alternatives.

Plastic (Dominant) vs. Glass (Emerging)

Plastic remains the dominant material in the US arterial blood-collection-devices market due to its affordability, lightweight nature, and versatility in production. Its ability to be molded into various shapes and sizes makes it ideal for mass production, allowing manufacturers to meet diverse healthcare requirements efficiently. Conversely, glass is emerging as a notable alternative, particularly in sectors demanding higher accuracy and a reduction in sample contamination. The resurgence of glass can be attributed to innovations that make it safer and easier to handle, alongside heightened regulatory standards. As healthcare providers continue to seek reliable and sustainable options, the significance of both materials will evolve, reflecting changing preferences and technological advancements in the market.

## Competitive Benchmarking

The arterial blood-collection-devices market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on enhancing patient outcomes. Key players such as Abbott Laboratories (US), Becton Dickinson and Company (US), and Cardinal Health, Inc. (US) are at the forefront of this dynamic environment. Abbott Laboratories (US) emphasizes innovation in its product offerings, particularly in developing advanced blood collection systems that enhance safety and efficiency. Becton Dickinson and Company (US) focuses on expanding its global footprint through strategic acquisitions and partnerships, thereby strengthening its market position. Cardinal Health, Inc. (US) is actively pursuing digital transformation initiatives to optimize its supply chain and improve service delivery, which collectively influences the competitive dynamics of the market.
The business tactics employed by these companies include localizing manufacturing to reduce costs and enhance responsiveness to market demands. The market structure appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Abbott Laboratories (US) and Becton Dickinson and Company (US) suggests a trend towards consolidation, as these firms leverage their resources to gain competitive advantages.
In October 2025, Abbott Laboratories (US) announced the launch of a new line of blood collection devices designed to minimize contamination risks. This strategic move is significant as it aligns with the growing emphasis on patient safety and infection control, potentially positioning Abbott as a leader in this niche segment. The introduction of these devices may enhance their market share and reinforce their reputation for innovation.
In September 2025, Becton Dickinson and Company (US) completed the acquisition of a smaller competitor specializing in digital blood collection technologies. This acquisition is likely to bolster Becton Dickinson's capabilities in integrating digital solutions into their product offerings, thereby enhancing operational efficiency and customer engagement. Such strategic actions indicate a clear intent to lead in the digital transformation of the blood collection process.
In August 2025, Cardinal Health, Inc. (US) entered into a partnership with a technology firm to develop AI-driven analytics for blood collection processes. This collaboration is poised to revolutionize how data is utilized in the blood collection sector, potentially leading to improved patient outcomes and operational efficiencies. The integration of AI into their offerings may provide Cardinal Health with a competitive edge in a rapidly evolving market.
As of November 2025, current trends in the arterial blood-collection-devices market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive edge in the market.

## Report Scope

| MARKET SIZE 2024 | 443.45(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 467.04(USD Million) |
| MARKET SIZE 2035 | 784.27(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.32% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Abbott Laboratories (US), Becton Dickinson and Company (US), Terumo Corporation (JP), F. Hoffmann-La Roche AG (CH), Greiner Bio-One International GmbH (AT), Cardinal Health, Inc. (US), Smiths Medical (US), Medtronic plc (IE) |
| Segments Covered | Type, End User, Application, Material |
| Key Market Opportunities | Advancements in minimally invasive technologies enhance efficiency in the arterial blood-collection-devices market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in arterial blood-collection-devices, enhancing patient safety and efficiency. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current market valuation of the US arterial blood-collection-devices market?**
A: The market valuation was $443.45 Million in 2024.

**Q: What is the projected market size for the US arterial blood-collection-devices market by 2035?**
A: The projected market size is $784.27 Million by 2035.

**Q: What is the expected CAGR for the US arterial blood-collection-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR is 5.32% during the forecast period 2025 - 2035.

**Q: Which segment had the highest valuation in the US arterial blood-collection-devices market in 2024?**
A: Collection Tubes had the highest valuation at $143.45 Million in 2024.

**Q: What are the key applications of arterial blood-collection-devices in the US market?**
A: Key applications include Diagnostic Testing, Therapeutic Procedures, and Blood Donation.

**Q: Which end user segment contributed the most to the market in 2024?**
A: Hospitals contributed the most, with a valuation of $177.38 Million in 2024.

**Q: What materials are primarily used in the manufacturing of arterial blood-collection-devices?**
A: The primary materials include Plastic, Glass, and Synthetic Materials.

**Q: Who are the leading companies in the US arterial blood-collection-devices market?**
A: Key players include Abbott Laboratories, Becton Dickinson and Company, and Terumo Corporation.

**Q: What was the valuation of Safety Blood Collection Devices in 2024?**
A: Safety Blood Collection Devices had a valuation of $144.79 Million in 2024.

**Q: How does the market for Diagnostic Laboratories compare to that of Blood Banks in 2024?**
A: Diagnostic Laboratories had a valuation of $133.04 Million, slightly higher than Blood Banks at $133.04 Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-arterial-blood-collection-devices-market-12924*